Clinical Trials · NCT00430183
Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
- Phase
- Phase 3
- Recruitment status
- Active Not Recruiting
- Sponsor
- Alliance for Clinical Trials in Oncology
- Enrollment
- 788
- Start date
- May 2007
- Locations
- 226 sites, United States, Canada
- Primary endpoint
- Proportion of Biochemical Progression-Free Survival (bPFS Proportion) at 3 Years